24dimetoksüfenüülacetonitriil

24-Dimetoksüfenilpropionamid, commonly known as 2C-D, is a synthetic psychedelic compound belonging to the phenethylamine class. It was first synthesized in the 1960s by Alexander Shulgin, a chemist and pharmacologist known for his extensive research on psychoactive substances. 2C-D is part of the 2C family of compounds, which are characterized by their hallucinogenic and stimulant effects.

The compound is typically consumed orally, often in tablet or capsule form, and its effects generally begin within 30 to 60 minutes, lasting for approximately 4 to 6 hours. Users commonly report visual enhancements, emotional openness, and mild stimulant effects, though the experience can vary widely depending on dosage, setting, and individual physiology. At higher doses, 2C-D may induce more intense hallucinations, including geometric patterns, synesthesia, and altered perceptions of time and space.

Due to its psychoactive properties, 2C-D has been subject to legal restrictions in many countries. In the United States, it is classified as a Schedule I controlled substance under the Federal Analogue Act, which prohibits its manufacture, distribution, or possession without authorization. Similar restrictions exist in other jurisdictions, where it is often regulated alongside other psychedelics.

Research on 2C-D remains limited compared to more widely studied substances like LSD or psilocybin. Its pharmacological mechanisms are not fully understood, but it is believed to act as a serotonin receptor agonist, particularly at the 5-HT2A receptor, which is also targeted by other psychedelics. The compound has been explored in limited preclinical studies, though clinical research is scarce.

As with all psychoactive substances, 2C-D carries risks, including potential for adverse reactions such as anxiety, paranoia, or physical discomfort. Its use is not recommended without proper knowledge of its effects and potential dangers. Due to its illegal status in many places, obtaining the compound may involve legal and health-related risks.